Search Results
Results found for "David Minh"
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
Get ready to dive into some discoveries and mind-blowing breakthroughs with us! This Week’s Highlights: Congrats to: Our contributor, Cam Sinh Lu , who has just released an incredible with his team: Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR China M Payne , Cam Sinh
- 📰 GPCR Weekly News, October 30 to November 4, 2023
with decitabine in relapsed or refractory acute myeloid leukemia Methods & Updates in GPCR Research Mining
- New role of β-arrestins in MOR signaling
With this in mind one of the proposals is to take advantage of biased agonism, i.e. when the same receptor
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
After 90 min (indicated with an arrow), the measurement was paused, and dissociation was initiated by BBV/well (CD3R = 0.7 nM), and different concentrations of corresponding dopaminergic ligands for 180 min well) were incubated with 1 nM CELT-419 and different concentrations of Dopamine or Spiperone for 180 min Side Effects of a Dopamine Agonist Therapy for Parkinson’s Disease: A Mini-Review of Clinical Pharmacology R.; Min, M.; Kopanchuk, S.; Rinken, A.
